We are very pleased to extend this important relationship with Covidien under terms that both parties embrace, said Bruce Barrett, Somanetics’ president and chief executive officer.
Somanetics develops, manufactures and markets the In Vivo Optical Spectroscopy (INVOS) System.
Covidien PLC, formerly Covidien Ltd, is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings.
